Difficulty: Medium
Average Score: 90%
Practice
The MOST vital initial treatment in the management of severe asthma exacerbations is
Correct answer
B
Rationale
In the management of severe asthma exacerbations in pediatric patients, the MOST vital initial treatment is the administration of an inhaled B-agonist, making option B the correct answer. In asthma exacerbations, bronchospasm and airway inflammation are common, and inhaled B-agonists like albuterol act quickly to dilate the airways, improving airflow and decreasing respiratory distress.
Supplemental oxygen (option A) is important in the management of asthma exacerbations to address hypoxemia, but it is not the MOST vital initial treatment. Intramuscular injection of epinephrine (option C) is typically reserved for anaphylactic reactions, not for asthma exacerbations. Inhaled ipratropium (option D) can be used as an adjunct in severe asthma exacerbations, but it is not the MOST vital initial treatment.
In an educational context, understanding the prioritization of treatments in pediatric asthma exacerbations is crucial for nurses caring for children with respiratory conditions. Knowing that inhaled B-agonists are the cornerstone of initial management can help nurses intervene promptly and effectively to improve outcomes in pediatric patients experiencing severe asthma exacerbations.
Supplemental oxygen (option A) is important in the management of asthma exacerbations to address hypoxemia, but it is not the MOST vital initial treatment. Intramuscular injection of epinephrine (option C) is typically reserved for anaphylactic reactions, not for asthma exacerbations. Inhaled ipratropium (option D) can be used as an adjunct in severe asthma exacerbations, but it is not the MOST vital initial treatment.
In an educational context, understanding the prioritization of treatments in pediatric asthma exacerbations is crucial for nurses caring for children with respiratory conditions. Knowing that inhaled B-agonists are the cornerstone of initial management can help nurses intervene promptly and effectively to improve outcomes in pediatric patients experiencing severe asthma exacerbations.